Dr. Howard Smith Oncall

Eisai Inc. is recalling Belviq (locaserin), a weight loss drug.  Last month, I reported that this medication had been linked to an increased incidence of pancreatic, colorectal, and lung cancer.  Now it is being recalled and withdrawn.  Anyone taking locaserin should speak with their doctors about an alternative.  Dispose of the unused medication.  The FDA is not recommending special screening for patients that have taken the drug.  It does recommend that prescribers notify their patients and report adverse effects.   #dieting #cancer